<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               2	DOSAGE AND ADMINISTRATION<BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           <BR>                              Healing of EE: 60 mg once daily for up to 8 weeks. (2.1)<BR>                           <BR>                              Maintenance of healed EE: 30 mg once daily for up to 6 months.  (2.1)<BR>                           <BR>                              Symptomatic non-erosive GERD: 30 mg once daily for 4 weeks. (2.1)<BR>                           <BR>                              Hepatic impairment: Consider 30 mg maximum daily dose for patients with moderate hepatic impairment (Child-Pugh Class B).  No studies were conducted in patients with severe hepatic impairment (Child-Pugh Class C).  (2.2, 8.7)<BR>                           KAPIDEX can be taken without regard to food.  (2.3)<BR>                           KAPIDEX should be swallowed whole. Alternatively, capsules can be opened, sprinkled on one tablespoon of applesauce, and swallowed immediately.  (2.3)<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.1	Recommended Dose<BR>                     <BR>                        KAPIDEX is available as capsules in 30 mg and 60 mg strengths for adult use. Directions for use in each indication are summarized in Table 1. <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="100%" ID="table1"><BR>                           <caption>Table 1: KAPIDEX Dosing Recommendations</caption><BR>                           <col width="33%" align="center" valign="top"/><BR>                           <col width="34%" align="center" valign="top"/><BR>                           <col width="33%" align="center" valign="top"/><BR>                           <thead><BR>                              <tr><BR>                                 <th styleCode="Rrule">Indication</th><BR>                                 <th styleCode="Rrule">Recommended Dose</th><BR>                                 <th>Frequency</th><BR>                              </tr><BR>                           </thead><BR>                           <tbody><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Rrule">Healing of EE</td><BR>                                 <td styleCode="Rrule">60 mg</td><BR>                                 <td>Once daily for up to 8 weeks</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Rrule">Maintenance of Healed EE</td><BR>                                 <td styleCode="Rrule">30 mg</td><BR>                                 <td>Once daily<footnote>Controlled studies did not extend beyond 6 months.</footnote><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Rrule">Symptomatic Non-Erosive GERD</td><BR>                                 <td styleCode="Rrule">30 mg</td><BR>                                 <td>Once daily for 4 weeks</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                     <BR><BR><BR><BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.2	Special Populations<BR>                     <BR>                        No adjustment for KAPIDEX is necessary for patients with mild hepatic impairment (Child-Pugh Class A). Consider a maximum daily dose of 30 mg for patients with moderate hepatic impairment (Child-Pugh Class B).  No studies have been conducted in patients with severe hepatic impairment (Child-Pugh Class C)  [see Use in Specific Populations (8.7) and Clinical Pharmacology (12.5)].<BR>                        <BR>                        No dosage adjustment is necessary for elderly patients or for patients with renal impairment [see Clinical Pharmacology (12.5)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.3	Important Administration Information<BR>                     <BR>                        KAPIDEX can be taken without regard to food.<BR>                        KAPIDEX should be swallowed whole. <BR>                        <BR>                           Alternatively, KAPIDEX capsules can be opened and administered as follows:<BR>                                 <BR>                                    –Open capsule;<BR>                                 <BR>                                    –Sprinkle intact granules on one tablespoon of applesauce;<BR>                                 <BR>                                    –Swallow immediately.<BR>                              <BR>                           <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>